SYNGENE.NS Profit & Loss
Syngene International Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 00:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹31.93 Bn | ₹34.89 Bn | ₹36.42 Bn | ₹37.39 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.71 Bn | ₹0.91 Bn | ₹0.72 Bn | ₹0.71 Bn | OtherIncome |
| Total Income | ₹32.64 Bn | ₹35.79 Bn | ₹37.14 Bn | ₹38.09 Bn | Income |
| Cost of Materials Consumed | ₹9.02 Bn | ₹8.74 Bn | ₹9.25 Bn | ₹9.11 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-0.42 Bn | ₹0.57 Bn | ₹0.17 Bn | ₹0.07 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹8.42 Bn | ₹8.89 Bn | ₹9.84 Bn | ₹11.05 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.45 Bn | ₹0.47 Bn | ₹0.53 Bn | ₹0.49 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹3.67 Bn | ₹4.26 Bn | ₹4.33 Bn | ₹4.53 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹5.57 Bn | ₹6.55 Bn | ₹6.74 Bn | ₹7.97 Bn | OtherExpenses |
| Total Expenses | ₹26.70 Bn | ₹29.47 Bn | ₹30.86 Bn | ₹33.22 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹5.94 Bn | ₹6.32 Bn | ₹6.28 Bn | ₹4.88 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹-0.11 Bn | ₹0.32 Bn | ₹-0.77 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹5.94 Bn | ₹6.21 Bn | ₹6.60 Bn | ₹4.11 Bn | ProfitBeforeTax |
| Tax Expense | ₹1.29 Bn | ₹1.11 Bn | ₹1.64 Bn | ₹0.94 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹4.64 Bn | ₹5.10 Bn | ₹4.96 Bn | ₹3.17 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹0.00 Bn | N/A | ₹0.00 Bn | ₹0.00 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹11.59 | ₹12.71 | ₹12.35 | ₹7.87 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹11.51 | ₹12.69 | ₹12.34 | ₹7.87 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from SYNGENE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).